4//SEC Filing
Glicklich Alan 4
Accession 0001209191-20-054253
CIK 0001435049other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 9:15 PM ET
Size
10.8 KB
Accession
0001209191-20-054253
Insider Transaction Report
Form 4
Glicklich Alan
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-10-06+62,660→ 62,660 totalExercise: $14.77Exp: 2030-10-05→ Common Stock (62,660 underlying) - Award
Restricted Stock Units (RSU) (Common Stock)
2020-10-06+21,311→ 21,311 totalExp: 2030-10-05→ Common Stock (21,311 underlying) - Award
Stock Option (right to buy)
2020-10-05+242,662→ 242,662 totalExercise: $0.42Exp: 2030-04-21→ Common Stock (242,662 underlying)
Footnotes (5)
- [F1]The stock option vests as to 25% of the total shares on April 20, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F2]Received in connection with the merger of Private Chinook into the Issuer in exchange for a stock option to acquire 830,500 shares of Private Chinook common stock for $0.12 per share.
- [F3]The stock option vests as to 25% of the total shares on October 6, 2021, and thereafter vests as to 1/36 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F4]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F5]The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on October 6, 2021, until fully vested subject to the reporting person's provision of service to the Issuer on each vesting date.
Documents
Issuer
ADURO BIOTECH, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001823197
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 9:15 PM ET
- Size
- 10.8 KB